Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Future Cardiology|December 20, 2016
Novel strategies for assessing platelet reactivityMohammad Algahtani, Stan HeptinstallPlatelets|July 10, 2018
Platelet aggregation measured by single-platelet counting and using PFA-100 devicesNatalia Dovlatova, Stan HeptinstallBritish Journal of Clinical Pharmacology|April 27, 2011
Anti-platelet therapy: ADP receptor antagonistsYanushi Dullewe Wijeyeratne, Stan HeptinstallExpert Review of Clinical Pharmacology|June 16, 2012
Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromesYanushi Dullewe Wijeyeratne, Rashi Joshi, Stan HeptinstallPlatelets|April 19, 2018
Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disordersPhilip M Bath, Jane May, Stan HeptinstallJournal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Triple antiplatelet therapy for secondary prevention of recurrent ischemic strokeMark Willmot, Lian Zhao, Stan Heptinstall, et al.Platelets|December 19, 2002
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart diseaseRobert F Storey, Robert G Wilcox, Stan HeptinstallThrombosis Research|January 26, 2005
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirinRobert F Storey, Jane A May, Stan HeptinstallPlatelets|March 23, 2012
PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptorsJacqueline R Glenn, Ann E White, David Iyu, et al.Thrombosis and Haemostasis|January 17, 2003
Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62PThomas Scholz, Uta Temmler, Siegfried Krause, et al.Pageof 8